Skip to main content
Journal of Genetic Engineering and Biotechnology
Fig. 4 | Journal of Genetic Engineering and Biotechnology

Fig. 4

From: IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy

Fig. 4

Study overview and key points. In this summarized figure, antiviral triple treatment (SOV/RBV + Peg-INF) was selected due to its favorable outcome on liver damage and fibrosis compared to dual treatment. Fibrosis state was evaluated by FibroScan. SVR: Sustained virologic response. Biochemical parameters are liver function tests including alanine and aspartate aminotransferase (ALT&AST), albumin, and total bilirubin

Back to article page